Piracetam CAS:7491-74-9 oxiracetam ukungcola V Oxiracetam-5

I-Piracetam yi-cyclic derivative ye-neurotransmitter gamma-aminobutyric acid (GABA), eyaqala ukuthengiswa kwi-1971 yi-UCB Pharma.Yayiyeyokuqala “i-nootropic” ichiza[1], iarhente esebenza kwingqondo ngaphandle kokubangela ukuthomalalisa okanye ukuvuselela.Nangona iindlela zokusebenza zepiracetam zingakacaciswa ngokupheleleyo, zinefuthe kwimisebenzi ye-neuronal kunye ne-vascular.Ngaphezu koko, iziphumo ze-vascular ziyi-peripheral kunye ne-central, oku kuthetha ukuba inzuzo yekliniki ye-piracetam ihamba ngaphaya kweempawu zayo ze-nootropic.Enyanisweni, i-piracetam ngoku iboniswe ukuba isetyenziswe kwi-vertigo, i-dyslexia, i-cortical myoclonus kunye ne-sickle cell anemia ngaphezu kokuphazamiseka kwengqondo okuhlobene nobudala.IPiracetam sele ikhona iminyaka engaphezu kwama-40.Ukusebenza kwayo kuye kwabhalwa kwiingxaki zengqondo kunye nokuphazamiseka kwengqondo, i-vertigo, i-cortical myoclonus, i-dyslexia, kunye ne-sickle cell anemia, nangona kunjalo, ukusetyenziswa kweklinikhi kule meko akukasungulwa.I-Piracetam nayo ineempembelelo kwinkqubo ye-vascular ngokunciphisa i-erythrocyte adhesion kwi-vascular endothelium, ithintele i-vasospasm kunye ne-microcirculation.